35. Pemphigus
87 clinical trials,   114 drugs   (DrugBank: 37 drugs),   17 drug target genes,   158 drug target pathways

Searched query = "Pemphigus"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03762265
(ClinicalTrials.gov)
January 8, 201929/11/2018A Study of PRN1008 in Patients With PemphigusA Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor PRN1008 in Moderate to Severe PemphigusPemphigusDrug: PRN1008 Oral Tablet;Drug: Placebo Oral TabletPrincipia Biopharma Inc.NULLRecruiting18 Years80 YearsAll120Phase 3United States;Argentina;Australia;Bulgaria;Canada;Croatia;France;Germany;Greece;Israel;Italy;Poland;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom